Monocyte Traffic and Neuropathogenesis of AIDS

$423,830R01FY2016NSNIH

Boston College, Chestnut Hill MA

Investigators

Linked publications & trials

Paper 35216002 Paper 30652349 Paper 29776458 Paper 29750804 Paper 29345061 Paper 28931681 Paper 28462488 Paper 28204544 Paper 28141779 Paper 28093272 Paper 27544476 Paper 27157989 Paper 26429776 Paper 26185285 Paper 26107380 Paper 26041280 Paper 25963554 Paper 25915601 Paper 25689120 Paper 25502752 Paper 25205684 Paper 25197827 Paper 25144219 Paper 24928039 Paper 24524407 Paper 24041790 Paper 23939235 Paper 23772617 Paper 23435298 Paper 23418159 Paper 23032411 Paper 22820791 Paper 22322298 Paper 22167311 Paper 22098563 Paper 21917896 Paper 21628670 Paper 21514427 Paper 21494901 Paper 21494695 Paper 21463330 Paper 21381104 Paper 21337426 Paper 20600075 Paper 20595631 Paper 20479889 Paper 20419144 Paper 20373387 Paper 20099249 Paper 19843579 Paper 19780178 Paper 19400864 Paper 19398702 Paper 19383966 Paper 19349370 Paper 16798673 Paper 16507898 Paper 16260389 Paper 16110325 Paper 15994781 Paper 15758162 Paper 15385254 Paper 15145603 Paper 12960230 Paper 12458041 Paper 12163382 Paper 12052920 Paper 11777554 Paper 11596124 Paper 11498257 Paper 11304551

Abstract

DESCRIPTION (provided by applicant): Despite successful ART that keeps HIV at non-detectable levels in plasma, HIV is not eradicated and when patients are taken off therapy, virus can quickly rebound. In addition, it is recognized that chronic immune activation occurs in patients on successful ART and the CNS effects of this include cognitive dysfunction. The source of the rebounding virus and cells that are activated with chronic infection include monocyte/macrophages. In this competitive renewal application we propose to study: 1) mechanisms that establish and maintain persistence of SIV- DNA in the CNS, 2) monocyte/macrophages that traffic out of the CNS that can be viral infected. We propose to use ART alone and in combination with a new oral form of a polyamine synthesis inhibitor, termed PA300, that targets monocyte/macrophage activation, traffic and infection. We propose to study monocyte/macrophages in blood that traffic to the CNS, macrophage accumulation in the CNS that establishes and maintains reservoirs of proviral DNA, and study the effects of ART and PA300 on this reservoir. Next, the effects of ART and PA300 on the traffic of CD163+ macrophages out of the CNS to peripheral lymph organs will be studied. Successful completion of this application will ascertain monocyte/macrophage subtypes in blood and the CNS that are proviral reservoirs, the effects of ART and PA300 to clear these reservoirs, and their effects on SIV infected cells leaving the CNS.

View original record on NIH RePORTER →